Jaano & Seekho – Know More. Think Deeper. Stay Ahead.
ज्ञान की पाठशाला
Why You Shouldn’t Compare Your Fitness Progress with Others By Sohamjita Roy , It’s easy to fall into the trap of comparing your fitness journey to someone else’s. Whether it’s their faster results, different workout routines, or seemingly effortless success, the temptation is always there. But comparing your progress to others is rarely beneficial, and…
Home Loan EMI vs. Renting: Which is the Better Financial Decision? If you’re in your 30s or early 40s, you may be wondering whether it’s smarter to buy a home through a home loan or continue renting. It’s important to recognize that this isn’t an apples-to-apples comparison since both come with distinct pros and cons….
How to Invest Your Monthly Surplus Wisely: A Guide to Achieving Financial Goals? At times, you may find yourself with some extra money at the end of the month, and deciding where to invest it can be challenging. Making smart investment choices with your monthly surplus is crucial for meeting both short-term and long-term financial…
The Connection Between Alzheimer’s and Menopause: What Every Woman Should Know Alzheimer’s disease affects nearly 50 million people globally, and this number is expected to surge to 75 million by 2030 and 131.5 million by 2050. In the United States alone, out of the 5.5 million individuals aged 65 and older living with Alzheimer’s, 3.4…
Leading Hidradenitis Suppurativa Treatments in the Market Currently, some of the top medications for treating hidradenitis suppurativa (HS) include BIMZELX (bimekizumab) by UCB Biopharma, COSENTYX (secukinumab) by Novartis, and HUMIRA (adalimumab) by AbbVie/Eisai. Until 2023, HUMIRA dominated the market, even though its US patent expired in December 2016. AbbVie’s strong patent defense in the US…
Some basics of Pharmacokinetics (PK) analysis: Pharmacokinetics refers to the study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. The pharmacokinetic analysis set is created to analyze PK data collected from study participants. This set typically includes patients who have received the drug of interest and have available PK data, such…
From ‘After’ to ‘Before’: Smita Bhatnagar’s Evolution Through TC21 In April 2024, I, Smita Bhatnagar, celebrated a significant milestone in my fitness journey by sharing my ‘before’ and ‘after’ photos. What was once a remarkable transformation is now my new ‘before,’ thanks to my incredible journey with the TC21 Transformation Challenge. This experience has not…
Gut Reset? Gut Detox? Gut Cleanse? – What You Need to Know! Author: Prachi Gupta, Coach, Fittr In today’s world, terms like gut reset, gut detox, and gut cleanse have become buzzwords, frequently popping up on social media. But before you jump on the latest trends, let’s clarify a few essential facts! 🦠 What Is…
Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer Bristol Myers Squibb (BMS) is set to push its PD-1/LAG-3 combination therapy, Opdualag, into phase 3 trials for first-line non-small cell lung cancer (NSCLC), two years after its initial FDA approval in melanoma. The registrational trial, named RELATIVITY1093, will evaluate Opdualag,…
Keytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care Merck’s Keytruda (pembrolizumab) has achieved a significant milestone in the fight against early-stage triple-negative breast cancer (TNBC), with new data demonstrating a substantial improvement in overall survival rates. This development follows an earlier controversy over its approval based on preliminary endpoints. At the…
